STA
JUNO

Summit Trail Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

Summit Trail Advisors’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-288
Closed -$24K – 2108
2017
Q4 		$24K Buy
+288
New +$14.4K ﹤0.01% 1002

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Summit Trail Advisors's JUNO Position: Q1 2018 in Review

Summit Trail Advisors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 288 shares — an estimated $24K sold.

Summit Trail Advisors first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $24K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Summit Trail Advisors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Summit Trail Advisors sold 288 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $24K.
  • Summit Trail Advisors first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
  • Summit Trail Advisors's Juno Therapeutics, Inc. position peaked at $24K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Summit Trail Advisors's 13F filing for Q1 2018, filed 21 May 2018.